TARA OSTROWSKY: Open Payments
NPI 1588060313 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$889 in 43 payments from 11 companies in 2025. Trend: 2023 $1,175 · 2024 $1,234 · 2025 $889
Food & beverage: $889
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $162 |
| ABBVIE INC. | 8 | $151 |
| Novo Nordisk Inc | 7 | $149 |
| GlaxoSmithKline, LLC. | 4 | $100 |
| Lilly USA, LLC | 5 | $83 |
| Amgen Inc. | 4 | $67 |
| PFIZER INC. | 3 | $52 |
| Dynavax Technologies Corporation | 3 | $48 |
| Exact Sciences Corporation | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, MOUNJARO, QULIPTA, Ozempic, VRAYLAR, Heplisav-B, Wegovy.
Industry payments across FL — which companies pay providers there.
